Vitex agnus-castus extracts for female reproductive disorders: A systematic review of clinical trials

Planta Medica

Volumn 79, Issue 7, 2013, Pages 562-575

  Van Die, M Diana ^a   Burger, Henryg ^b   Teede, Helenaj ^c,d   Bone, Kerrym ^e,f  

^a RMIT UNIVERSITY   (Australia)

^b HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d Southern Health   (Australia)

^e UNIVERSITY OF NEW ENGLAND   (Australia)

^f Integria (MediHerb)   (Australia)

Author keywords

hyperprolactinaemia; mastalgia; premenstrual; systematic review; Verbenaceae; Vitex agnus castus

Indexed keywords

BROMOCRIPTINE; BROMOCRIPTINE MESILATE; ESTRADIOL; FLUOXETINE; MAGNESIUM OXIDE; PLACEBO; PROGESTERONE; PROLACTIN; PYRIDOXINE; VITEX AGNUS CASTUS EXTRACT;

ABSCESS; ACNE; COCHRANE LIBRARY; DATA BASE; DRUG EFFICACY; DRUG SAFETY; EMBASE; FEMALE REPRODUCTIVE SYSTEM DISORDER; GASTROENTERITIS; GYNECOLOGIC DISEASE; HEADACHE; HUMAN; HYPERPROLACTINEMIA; LUTEAL PHASE; MASTALGIA; MEDLINE; META ANALYSIS; PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYNDROME; PROLACTIN RELEASE; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT; UROGENITAL SYSTEM FUNCTION AND REPRODUCTION; URTICARIA; VITEX AGNUS CASTUS;

FEMALE; HUMANS; HYPERPROLACTINEMIA; LUTEAL PHASE; MASTODYNIA; PHYTOTHERAPY; PLANT EXTRACTS; PREMENSTRUAL SYNDROME; PROLACTIN; REPRODUCTIVE HEALTH; VITEX;

VERBENACEAE; VITEX; VITEX AGNUS-CASTUS;

EID: 84877873290     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0032-1327831     Document Type: Review

References (57)

1. Upchurch D. M., Chyu L., Greendale G. A., Utts J., Bair Y. A., Zhang G., Gold E. B. Complementary and alternative medicine use among American women: findings from The National Health Interview Survey, 2002. J Womens Health (Larchmt): 2007; 16 102 113
2. Upchurch D. M., Dye C. E., Chyu L., Gold E. B., Greendale G. A. Demographic, behavioral, and health correlates of complementary and alternative medicine and prayer use among midlife women: 2002. J Womens Health (Larchmt): 2010; 19 23 30
3. Domoney C. L., Vashisht A., Studd J. W. Use of complementary therapies by women attending a specialist premenstrual syndrome clinic. Gynecol Endocrinol: 2003; 17 13 18 (Pubitemid 36349877)
4. Christie S., Walker A. F. Vitex agnus-castus L.: (1) A review of its traditional and modern therapeutic use; (2) Current use from a survey of practitioners. Eur J Herbal Med: 1997; 3 29 45
5. [no authors listed] Agnus castus also effective in fertility disorders. Exeter The 5th Annual Symposium on Complementary Health Care: 1999
6. Van Die M. D., Burger H. G., Bone K. M., Cohen M. M., Teede H. J. Hypericum perforatum with Vitex agnus-castus in menopausal symptoms: a randomized, controlled trial. Menopause: 2009; 16 156 163
7. Singh B. B., Berman B. M., Simpson R. L., Annechild A. Incidence of premenstrual syndrome and remedy usage: a national probability sample study. Altern Ther Health Med: 1998; 4 75 79 (Pubitemid 128548535)
8. Winer S. A., Rapkin A. J. Premenstrual disorders: prevalence, etiology and impact. J Reprod Med: 2006; 51 339 347
9. Halbreich U., Borenstein J., Pearlstein T., Kahn L. S. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology: 2003; 28 03 1 23 (Pubitemid 39658675)
10. Frackiewicz E. J., Shiovitz T. M. Evaluation and management of premenstrual syndrome and premenstrual dysphoric disorder. J Am Pharm Assoc (Wash): 2001; 41 437 447
11. Ader D. N., South-Paul J., Adera T., Deuster P. A. Cyclical mastalgia: prevalence and associated health and behavioral factors. J Psychosom Obstet Gynaecol: 2001; 22 71 76 (Pubitemid 32613414)
12. Halbreich U., Ben-David M., Assael M., Bornstein R. Serum-prolactin in women with premenstrual syndrome. Lancet: 1976; 2 654 656
13. Muhlenstedt D., Bohnet H. G., Hanker J. P., Schneider H. P. Short luteal phase and prolactin. Int J Fertil: 1978; 23 213 218 (Pubitemid 9047181)
14. Dietrich M., Hinney B., Link M., Kuhn W., Wuttke W. Latent hyperprolactinaemia as a cause of mastodynia and luteal function impairment. Kyoto, Japan 5th International Congress Prolactin: 1988
15. Wuttke W., Gorkow C., Jarry H. Dopaminergic compounds in Vitex agnus-castus. In: Leow D., Rietbrock N. editors Phytopharmaka in Forschung und klinischer Anwendung. Darmstadt Steinkopff Verlag: 1995; 81 91
16. Yen S. The human menstrual cycle: neuroendocrine regulation. In: Yen S., Jaffe R. B., Barbieri R. L. editors Reproductive endocrinology. Physiology, pathophysiology and clinical management. Philadelphia WB Saunders Company: 1999; 191 217
17. Wuttke W., Jarry H., Christoffel V., Spengler B., Seidlova-Wuttke D. Chaste tree (Vitex agnus-castus)-pharmacology and clinical indications. Phytomedicine: 2003; 10 348 357 (Pubitemid 36597173)
18. Wuttke W. The use of chasteberry (Vitex agnus castus) extract in gynecology. Gynäkol Endokrinol: 2008; 6 82 86
19. Noack M. Our experiences with Agnus castus oligoplex for increasing milk yield. Dtsch Med Wochenschr: 1943; 9 204 206
20. Bautze H. J. Investigations on the influence of Agnus castus on the breastfeeding performance. Medwelt: 1953; 4 189 190
21. Ciotta L., Pagano I., Stracquadanio M., Di Leo S., Ando A., Formuso C. Psychic aspects of the premenstrual dysphoric disorders. New therapeutic strategies: our experience with Vitex agnus castus. Minerva Ginecol: 2011; 63 237 245
22. Schellenberg R. Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study. BMJ: 2001; 322 134 137 (Pubitemid 32116190)
23. Zamani M., Neghab N., Torabian S. Therapeutic effect of Vitex agnus castus in patients with premenstrual syndrome. Acta Med Iran: 2012; 50 101 106
24. Turner S., Mills S. Y. A double-blind clinical trial on a herbal remedy for premenstrual syndrome: a case study. Complement Ther Med: 1993; 1 73 77
25. Higgins J. PT, Green S. Cochrane handbook for systematic reviews of interventions (version 5.0.1). The Cochrane Collaboration: 2008; Available at http://www.cochrane-handbook.org Accessed May 13, 2012
26. Jadad A. R., Moore R. A., Carroll D., Jenkinson C., Reynolds D. J., Gavaghan D. J., McQuay H. J. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials: 1996; 17 1 12 (Pubitemid 26120810)
27. Gagnier J. J., Boon H., Rochon P., Moher D., Barnes J., Bombardier C. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med: 2006; 144 364 367 (Pubitemid 46768190)
28. Ma L., Lin S., Chen R., Wang X. Treatment of moderate to severe premenstrual syndrome with Vitex agnus castus (BNO 1095) in Chinese women. Gynaecol Endocrinol: 2010; 26 612 616
29. Ma L., Lin S., Chen R., Zhang Y., Chen F., Wang X. Evaluating therapeutic effect in symptoms of moderate-to-severe premenstrual syndrome with Vitex agnus castus (BNO 1095) in Chinese women. Aust N Z J Obstet Gynaecol: 2010; 50 189 193
30. [no authors listed] Agnus castus. UK Gerard House Promotional Brochure: 1988
31. He Z., Chen R., Zhou Y., Geng L., Zhang Z., Chen S., Yao Y., Lu J., Lin S. Treatment for premenstrual syndrome with Vitex agnus castus: A prospective, randomized, multi-center placebo controlled study in China. Maturitas: 2009; 63 99 103
32. Kilicdag E. B., Tarim E., Bagis T., Erkanli S., Aslan E., Ozsahin K., Kuscu E. Fructus agni casti and bromocriptine for treatment of hyperprolactinemia and mastalgia. Int J Gynaecol Obstet: 2004; 85 292 293 (Pubitemid 38622569)
33. Lauritzen C., Reuter H. D., Repges R., Bohnert K. J., Schmidt U. Treatment of premenstrual tension syndrome with Vitex agnus castus - Controlled, double-blind study versus pyridoxine. Phytomedicine: 1997; 4 183 189 (Pubitemid 127565762)
34. Pakgohar M., Moradi M., Jamshidi A. H., Mehran A. Assessment of Vitex agnus-castus L. extract effect on treatment of premenstrual syndrome. J Med Plants: 2009; 8 98 107, 185
35. Di Pierro F., Prazzoli R., Candidi C., Attolico M. Premenstrual syndrome: Controlled clinical trial with a fast acting form of a highly standardized extract of Vitex agnus castus. Giorn It Ost Ginecol: 2009; 31 153 157
36. Atmaca M., Kumru S., Tezcan E. Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder. Hum Psychopharmacol: 2003; 18 191 195 (Pubitemid 36526944)
37. Milewicz A., Gejdel E., Sworen H., Sienkiewicz K., Jedrzejak J., Teucher T., Schmitz H. Vitex agnus castus extract in the treatment of luteal phase defects due to latent hyperprolactinemia. Results of a randomized placebo-controlled double-blind study. Arzneimittelforschung: 1993; 43 752 756 (Pubitemid 23210991)
38. Dante G., Facchinetti F. Herbal treatments for alleviating premenstrual symptoms: a systematic review. J Psychosom Obstet Gynaecol: 2011; 32 42 51
39. Carmichael A. R. Can Vitex agnus castus be used for the treatment of mastalgia? What is the current evidence? Evid Based Complement Alternat Med: 2008; 5 247 250
40. Daniele C., Thompson Coon J., Pittler M. H., Ernst E. Vitex agnus castus: a systematic review of adverse events. Drug Saf: 2005; 28 319 332 (Pubitemid 40545767)
41. Jarry H., Leonhardt S., Gorkow C., Wuttke W. In vitro prolactin but not LH and FSH release is inhibited by compounds in extracts of Agnus castus: direct evidence for a dopaminergic principle by the dopamine receptor assay. Exp Clin Endocrinol: 1994; 102 448 454
42. Mertz P. G., Gorkow C., Schrodter A., Rietbrock S., Sieder C., Loew D., Dericks-Tan J. S., Taubert H. D. The effects of a special Agnus castus extract (BP1095E1) on prolactin secretion in healthy male subjects. Exp Clin Endocrinol Diabetes: 1996; 104 447 453 (Pubitemid 27033066)
43. Dericks-Tan J. SE, Schwinn P., Hildt C. Dose-dependent stimulation of melatonin secretion after administration of Agnus castus. Exp Clin Endocrinol Diabetes: 2003; 111 44 46 (Pubitemid 36336816)
44. Van Die M., Burger H., Teede H., Bone K. Vitex agnus-castus (Chaste-tree/berry) in the Treatment of Menopause-related Complaints. J Altern Complement Med: 2009; 15 853 862
45. Diaz B. L., Llaneza P. C. Endocrine regulation of the course of menopause by oral melatonin: first case report. Menopause: 2008; 15 388 392 (Pubitemid 351355006)
46. Jarry H., Spengler B., Porzel A., Schmidt J., Wuttke W., Christoffel V. Evidence for estrogen receptor beta-selective activity of Vitex agnus-castus and isolated flavones. Planta Med: 2003; 69 945 947 (Pubitemid 38005452)
47. Whelan A. M., Jurgens T. M., Naylor H. Herbs, vitamins and minerals in the treatment of premenstrual syndrome: a systematic review. Can J Clin Pharmacol: 2009; 16 407 429
48. Bryant M., Cassidy A., Hill C., Powell J., Talbot D., Dye L. Effect of consumption of soy isoflavones on behavioural, somatic and affective symptoms in women with premenstrual syndrome. Br J Nutr: 2005; 93 731 739 (Pubitemid 43906359)
49. Cos P., De Bruyne T., Apers S., Vanden Berghe D., Pieters L., Vlietinck A. J. Phytoestrogens: recent developments. Planta Med: 2003; 69 589 599 (Pubitemid 37041052)
50. Bendich A. The potential for dietary supplements to reduce premenstrual syndrome (PMS) symptoms. J Am Coll Nutr: 2000; 19 3 12 (Pubitemid 30090438)
51. Hagen I., Nesheim B. I., Tuntland T. No effect of vitamin B-6 against premenstrual tension. A controlled clinical study. Acta Obstet Gynecol Scand: 1985; 64 667 670 (Pubitemid 16133500)
52. Doll H., Brown S., Thurston A., Vessey M. Pyridoxine (vitamin B6) and the premenstrual syndrome: a randomized crossover trial. J R Coll Gen Pract: 1989; 39 364 368 (Pubitemid 19230006)
53. Wyatt K. M., Dimmock P. W., Jones P. W., Shaughn OBrien P. M. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review. BMJ: 1999; 318 1375 1381 (Pubitemid 29237827)
54. Gumm R., Cunnick G. H., Mokbel K. Evidence for the management of mastalgia. Curr Med Res Opin: 2004; 20 681 684 (Pubitemid 38685012)
55. Mansel R. E., Dogliotti L. European multicentre trial of bromocriptine in cyclical mastalgia. Lancet: 1990; 335 190 193 (Pubitemid 20054579)
56. Van Die M. D., Bone K. M., Burger H. G., Reece J. E., Teede H. J. Effects of a combination of Hypericum perforatum and Vitex agnus-castus on PMS-like symptoms in late-perimenopausal women: findings from a subpopulation analysis. J Altern Complement Med: 2009; 15 1045 1048
57. American Psychiatric Association Diagnostic and statistical manual of mental disorders. 3rd edition, revised (DSM-III-R). Washington DC APA: 1987; 715 718